Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BeiGene's Zanubrutinib to Be Approved in China

CPhI.CNMay 26, 2020

Tag: BeiGene , Zanubrutinib , mantle cell lymphoma , BTK Inhibitor

PharmaSources Customer Service